Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Politics for Pros- moderated -- Ignore unavailable to you. Want to Upgrade?

To: skinowski who wrote (758874)	3/8/2022 10:00:34 PM
From: alanrs	2 Recommendations Recommended By pak73 skinowski Respond to of 793677

Why are they running illegal bio weapons labs in Ukraine? I know there's a joke in there somewhere but the ghost of Groucho eludes me. Edit: Because they're too big to fit in a bathtub? A little lame. It's late.

To: skinowski who wrote (758874)	3/8/2022 10:21:45 PM
From: didjuneau	1 Recommendation Recommended By DinoNavarre Read Replies (2) \| Respond to of 793677

I worry about the mysterious meaning of this post you made. Sounds "spooky". Message 33723040 Do you remember what drew your attention to it? I heard that these labs were collecting Russian DNA to study. A lot of people in the red map area are genetically related to the Mongols from past invasions. Just sayin... The labs are apparently run by DTRA, a military operation that Dr. Robert Malone has worked with on pathogen and vaccine research. The State Department was bragging about them on their website up until recently. There's one in Georgia too - named after Senator Lugar. radiopatriot.net The article in the link above shows how it was a bipartisan effort between Lugar and then Senator Obama.

To: skinowski who wrote (758874)	3/8/2022 10:35:07 PM
From: Sdgla	2 Recommendations Recommended By pak73 skinowski Respond to of 793677

At this point I do not have any doubt. The entire crew (both sides) are still running the congress & WH while Trump is still under attack. Mission accomplished. #CCPMcConnell pic.twitter.com/dlWo0DGvn7 — NautPoso 🇮🇪🚀 (@NautPoso) February 9, 2022

To: skinowski who wrote (758874)	3/9/2022 12:05:43 AM
From: Sdgla	1 Recommendation Recommended By DinoNavarre Read Replies (1) \| Respond to of 793677

Threat Reduction Program Extends Reach to Ukrainian Biological Facilities ARMS CONTROL TODAY William Huntington U.S. cooperation with Ukraine under the Nunn-Lugar Cooperative Threat Reduction (CTR) program was expanded Aug. 29 with an agreement to use U.S. CTR funds to improve security for pathogens stored at biological research and health facilities in the former Soviet republic. Under the agreement, CTR funds will for the first time flow directly to projects aimed at securing pathogen strains and sensitive biological knowledge within Ukraine. The United States also will work to improve Ukrainian capabilities to detect, diagnose, and treat outbreaks of infectious diseases, as well as determine whether outbreaks are natural or the result of bioterrorism. The agreement was signed during the visit to Kiev of a high-level U.S. delegation led by Senate Foreign Relations Committee Chairman Richard Lugar (R-Ind.) and Senator Barack Obama (D-Ill.). Among the facilities in Ukraine intended to receive security upgrades are those once linked to the Soviet-era anti-plague network, which continue to store libraries of naturally occuring pathogens for the purposes of research and public health. Andy Fisher, spokesperson for Lugar, told Arms Control Today on Sept. 15 the anti-plague facilities “were threats and they are threats,” given the risk that poor security could allow terrorists access to pathogens. Fisher also cited the possibility that outdated operating procedures and equipment could result in the unintentional leakage of pathogens from these facilities, endangering the public health of the region. Cooperation under the new agreement will not be limited to physical security over pathogens. Funds also will be available for the peaceful employment of scientists whose skills and financial insecurity could render them potential targets for states or independent groups looking to acquire bioweapons capabilities. In addition, the agreement includes provisions for cooperation between U.S. and Ukrainian epidemiological laboratories in diagnosing disease outbreaks. Toward that end, pathogens from Ukrainian health and research facilities will be shared with U.S. partner laboratories. Under a CTR agreement with Azerbaijan, the United States last month also received a transfer of pathogens from similar facilities in that former Soviet republic. As a first step toward implementation of the agreement, the Defense Threat Reduction Agency (DTRA) will conduct an assessment of biological facilities in Ukraine to determine what sites will receive assistance. Funds within the current DTRA budget will cover the assessment phase; additional implementation funds could be appropriated in fiscal year 2007 and beyond. As the Aug. 29 agreement falls under the established CTR framework, neither Congress nor the Ukrainian Rada will need to provide further authorization before implementation begins. Negotiations on the Aug. 29 agreement spanned more than a year. One administration official who requested anonymity told Arms Control Today that inter-Ukrainian political and bureaucratic hurdles were surmounted by a combination of strong U.S.-Ukrainian relations and the presence of the high-level U.S. delegation. A press release from Lugar’s office specifically credited then-Prime Minister Yuliya Tymoshenko with breaking a “log jam within Ukrainian government bureaucracy.” armscontrol.org